Loading…

MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)

Objectives Radiomic involves testing the associations of a large number of quantitative imaging features with clinical characteristics. Our aim was to extract a radiomic signature from axial T2-weighted (T2-W) magnetic resonance imaging (MRI) of the whole prostate able to predict oncological and rad...

Full description

Saved in:
Bibliographic Details
Published in:European radiology 2021-02, Vol.31 (2), p.716-728
Main Authors: Gugliandolo, Simone Giovanni, Pepa, Matteo, Isaksson, Lars Johannes, Marvaso, Giulia, Raimondi, Sara, Botta, Francesca, Gandini, Sara, Ciardo, Delia, Volpe, Stefania, Riva, Giulia, Rojas, Damari Patricia, Zerini, Dario, Pricolo, Paola, Alessi, Sarah, Petralia, Giuseppe, Summers, Paul Eugene, Mistretta, Frnacesco Alessandro, Luzzago, Stefano, Cattani, Federica, De Cobelli, Ottavio, Cassano, Enrico, Cremonesi, Marta, Bellomi, Massimo, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933
cites cdi_FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933
container_end_page 728
container_issue 2
container_start_page 716
container_title European radiology
container_volume 31
creator Gugliandolo, Simone Giovanni
Pepa, Matteo
Isaksson, Lars Johannes
Marvaso, Giulia
Raimondi, Sara
Botta, Francesca
Gandini, Sara
Ciardo, Delia
Volpe, Stefania
Riva, Giulia
Rojas, Damari Patricia
Zerini, Dario
Pricolo, Paola
Alessi, Sarah
Petralia, Giuseppe
Summers, Paul Eugene
Mistretta, Frnacesco Alessandro
Luzzago, Stefano
Cattani, Federica
De Cobelli, Ottavio
Cassano, Enrico
Cremonesi, Marta
Bellomi, Massimo
Orecchia, Roberto
Jereczek-Fossa, Barbara Alicja
description Objectives Radiomic involves testing the associations of a large number of quantitative imaging features with clinical characteristics. Our aim was to extract a radiomic signature from axial T2-weighted (T2-W) magnetic resonance imaging (MRI) of the whole prostate able to predict oncological and radiological scores in prostate cancer (PCa). Methods This study included 65 patients with localized PCa treated with radiotherapy (RT) between 2014 and 2018. For each patient, the T2-W MRI images were normalized with the histogram intensity scale standardization method. Features were extracted with the IBEX software. The association of each radiomic feature with risk class, T-stage, Gleason score (GS), extracapsular extension (ECE) score, and Prostate Imaging Reporting and Data System (PI-RADS v2) score was assessed by univariate and multivariate analysis. Results Forty-nine out of 65 patients were eligible. Among the 1702 features extracted, 3 to 6 features with the highest predictive power were selected for each outcome. This analysis showed that texture features were the most predictive for GS, PI-RADS v2 score, and risk class; intensity features were highly associated with T-stage, ECE score, and risk class, with areas under the receiver operating characteristic curve (ROC AUC) ranging from 0.74 to 0.94. Conclusions MRI-based radiomics is a promising tool for prediction of PCa characteristics. Although a significant association was found between the selected features and all the mentioned clinical/radiological scores, further validations on larger cohorts are needed before these findings can be applied in the clinical practice. Key Points • A radiomic model was used to classify PCa aggressiveness. • Radiomic analysis was performed on T2-W magnetic resonance images of the whole prostate gland. • The most predictive features belong to the texture (57%) and intensity (43%) domains.
doi_str_mv 10.1007/s00330-020-07105-z
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2437853172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2478670145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS0EoqHwAiyQJTZlYfDv2MOmqiIoIxUhFViPHM-dxNVkPNieouQ9eR9MEkBiwcK6i_ud42MfhJ4z-ppRqt8kSoWghPJyNKOK7B-gBZOCE0aNfIgWtBaG6LqWZ-hJSneU0ppJ_RidCW4UVzVdoB8fbxuysgk6HG3nw9a7hJNfjzbPEXAfIh6Cs4PfF2KKIWWbATs7OohvscUjfMdu8KMvDM4hDAfJcY_teh0hJX8PYxlFDp132YfxEn-eVyTludvh0B98Jyibe8DTpoTBTYNz9MUyjHgecrRks5tCH-1BXiKc4uYNRDvt8MVVc7vEzTVhgjPz6il61NshwbPTPEdf37_7svxAbj5dN8urG-KEVplY0YHizFHby97RmjsQxtraCVkZoE7V1coIKXtmpKaV5V1tlbagqs70qhbiHF0cfcsLvs2Qcrv1ycEw2BHCnFouhTZKMM0L-vIf9C7McSzpCqVNpSmTqlD8SLnyJSlC307Rb23ctYy2v0pvj6W3pfT2UHq7L6IXJ-t5tYXuj-R3ywUQRyCV1biG-Pfu_9j-BLgUuuU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478670145</pqid></control><display><type>article</type><title>MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)</title><source>Springer Nature</source><creator>Gugliandolo, Simone Giovanni ; Pepa, Matteo ; Isaksson, Lars Johannes ; Marvaso, Giulia ; Raimondi, Sara ; Botta, Francesca ; Gandini, Sara ; Ciardo, Delia ; Volpe, Stefania ; Riva, Giulia ; Rojas, Damari Patricia ; Zerini, Dario ; Pricolo, Paola ; Alessi, Sarah ; Petralia, Giuseppe ; Summers, Paul Eugene ; Mistretta, Frnacesco Alessandro ; Luzzago, Stefano ; Cattani, Federica ; De Cobelli, Ottavio ; Cassano, Enrico ; Cremonesi, Marta ; Bellomi, Massimo ; Orecchia, Roberto ; Jereczek-Fossa, Barbara Alicja</creator><creatorcontrib>Gugliandolo, Simone Giovanni ; Pepa, Matteo ; Isaksson, Lars Johannes ; Marvaso, Giulia ; Raimondi, Sara ; Botta, Francesca ; Gandini, Sara ; Ciardo, Delia ; Volpe, Stefania ; Riva, Giulia ; Rojas, Damari Patricia ; Zerini, Dario ; Pricolo, Paola ; Alessi, Sarah ; Petralia, Giuseppe ; Summers, Paul Eugene ; Mistretta, Frnacesco Alessandro ; Luzzago, Stefano ; Cattani, Federica ; De Cobelli, Ottavio ; Cassano, Enrico ; Cremonesi, Marta ; Bellomi, Massimo ; Orecchia, Roberto ; Jereczek-Fossa, Barbara Alicja</creatorcontrib><description>Objectives Radiomic involves testing the associations of a large number of quantitative imaging features with clinical characteristics. Our aim was to extract a radiomic signature from axial T2-weighted (T2-W) magnetic resonance imaging (MRI) of the whole prostate able to predict oncological and radiological scores in prostate cancer (PCa). Methods This study included 65 patients with localized PCa treated with radiotherapy (RT) between 2014 and 2018. For each patient, the T2-W MRI images were normalized with the histogram intensity scale standardization method. Features were extracted with the IBEX software. The association of each radiomic feature with risk class, T-stage, Gleason score (GS), extracapsular extension (ECE) score, and Prostate Imaging Reporting and Data System (PI-RADS v2) score was assessed by univariate and multivariate analysis. Results Forty-nine out of 65 patients were eligible. Among the 1702 features extracted, 3 to 6 features with the highest predictive power were selected for each outcome. This analysis showed that texture features were the most predictive for GS, PI-RADS v2 score, and risk class; intensity features were highly associated with T-stage, ECE score, and risk class, with areas under the receiver operating characteristic curve (ROC AUC) ranging from 0.74 to 0.94. Conclusions MRI-based radiomics is a promising tool for prediction of PCa characteristics. Although a significant association was found between the selected features and all the mentioned clinical/radiological scores, further validations on larger cohorts are needed before these findings can be applied in the clinical practice. Key Points • A radiomic model was used to classify PCa aggressiveness. • Radiomic analysis was performed on T2-W magnetic resonance images of the whole prostate gland. • The most predictive features belong to the texture (57%) and intensity (43%) domains.</description><identifier>ISSN: 0938-7994</identifier><identifier>EISSN: 1432-1084</identifier><identifier>DOI: 10.1007/s00330-020-07105-z</identifier><identifier>PMID: 32852590</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Diagnostic Radiology ; Feature extraction ; Histograms ; Humans ; Image classification ; Imaging ; Immunoglobulins ; Internal Medicine ; Interventional Radiology ; Magnetic Resonance ; Magnetic Resonance Imaging ; Male ; Medical imaging ; Medicine ; Medicine &amp; Public Health ; Multivariate analysis ; Neuroradiology ; Prospective Studies ; Prostate cancer ; Prostatic Neoplasms - diagnostic imaging ; Prostatic Neoplasms - radiotherapy ; Radiation therapy ; Radiology ; Radiomics ; Resonance ; Retrospective Studies ; Risk ; Standardization ; Texture ; Ultrasound</subject><ispartof>European radiology, 2021-02, Vol.31 (2), p.716-728</ispartof><rights>European Society of Radiology 2020</rights><rights>European Society of Radiology 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933</citedby><cites>FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933</cites><orcidid>0000-0002-5339-8038</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32852590$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gugliandolo, Simone Giovanni</creatorcontrib><creatorcontrib>Pepa, Matteo</creatorcontrib><creatorcontrib>Isaksson, Lars Johannes</creatorcontrib><creatorcontrib>Marvaso, Giulia</creatorcontrib><creatorcontrib>Raimondi, Sara</creatorcontrib><creatorcontrib>Botta, Francesca</creatorcontrib><creatorcontrib>Gandini, Sara</creatorcontrib><creatorcontrib>Ciardo, Delia</creatorcontrib><creatorcontrib>Volpe, Stefania</creatorcontrib><creatorcontrib>Riva, Giulia</creatorcontrib><creatorcontrib>Rojas, Damari Patricia</creatorcontrib><creatorcontrib>Zerini, Dario</creatorcontrib><creatorcontrib>Pricolo, Paola</creatorcontrib><creatorcontrib>Alessi, Sarah</creatorcontrib><creatorcontrib>Petralia, Giuseppe</creatorcontrib><creatorcontrib>Summers, Paul Eugene</creatorcontrib><creatorcontrib>Mistretta, Frnacesco Alessandro</creatorcontrib><creatorcontrib>Luzzago, Stefano</creatorcontrib><creatorcontrib>Cattani, Federica</creatorcontrib><creatorcontrib>De Cobelli, Ottavio</creatorcontrib><creatorcontrib>Cassano, Enrico</creatorcontrib><creatorcontrib>Cremonesi, Marta</creatorcontrib><creatorcontrib>Bellomi, Massimo</creatorcontrib><creatorcontrib>Orecchia, Roberto</creatorcontrib><creatorcontrib>Jereczek-Fossa, Barbara Alicja</creatorcontrib><title>MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)</title><title>European radiology</title><addtitle>Eur Radiol</addtitle><addtitle>Eur Radiol</addtitle><description>Objectives Radiomic involves testing the associations of a large number of quantitative imaging features with clinical characteristics. Our aim was to extract a radiomic signature from axial T2-weighted (T2-W) magnetic resonance imaging (MRI) of the whole prostate able to predict oncological and radiological scores in prostate cancer (PCa). Methods This study included 65 patients with localized PCa treated with radiotherapy (RT) between 2014 and 2018. For each patient, the T2-W MRI images were normalized with the histogram intensity scale standardization method. Features were extracted with the IBEX software. The association of each radiomic feature with risk class, T-stage, Gleason score (GS), extracapsular extension (ECE) score, and Prostate Imaging Reporting and Data System (PI-RADS v2) score was assessed by univariate and multivariate analysis. Results Forty-nine out of 65 patients were eligible. Among the 1702 features extracted, 3 to 6 features with the highest predictive power were selected for each outcome. This analysis showed that texture features were the most predictive for GS, PI-RADS v2 score, and risk class; intensity features were highly associated with T-stage, ECE score, and risk class, with areas under the receiver operating characteristic curve (ROC AUC) ranging from 0.74 to 0.94. Conclusions MRI-based radiomics is a promising tool for prediction of PCa characteristics. Although a significant association was found between the selected features and all the mentioned clinical/radiological scores, further validations on larger cohorts are needed before these findings can be applied in the clinical practice. Key Points • A radiomic model was used to classify PCa aggressiveness. • Radiomic analysis was performed on T2-W magnetic resonance images of the whole prostate gland. • The most predictive features belong to the texture (57%) and intensity (43%) domains.</description><subject>Diagnostic Radiology</subject><subject>Feature extraction</subject><subject>Histograms</subject><subject>Humans</subject><subject>Image classification</subject><subject>Imaging</subject><subject>Immunoglobulins</subject><subject>Internal Medicine</subject><subject>Interventional Radiology</subject><subject>Magnetic Resonance</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Multivariate analysis</subject><subject>Neuroradiology</subject><subject>Prospective Studies</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Radiation therapy</subject><subject>Radiology</subject><subject>Radiomics</subject><subject>Resonance</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Standardization</subject><subject>Texture</subject><subject>Ultrasound</subject><issn>0938-7994</issn><issn>1432-1084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1uEzEUhS0EoqHwAiyQJTZlYfDv2MOmqiIoIxUhFViPHM-dxNVkPNieouQ9eR9MEkBiwcK6i_ud42MfhJ4z-ppRqt8kSoWghPJyNKOK7B-gBZOCE0aNfIgWtBaG6LqWZ-hJSneU0ppJ_RidCW4UVzVdoB8fbxuysgk6HG3nw9a7hJNfjzbPEXAfIh6Cs4PfF2KKIWWbATs7OohvscUjfMdu8KMvDM4hDAfJcY_teh0hJX8PYxlFDp132YfxEn-eVyTludvh0B98Jyibe8DTpoTBTYNz9MUyjHgecrRks5tCH-1BXiKc4uYNRDvt8MVVc7vEzTVhgjPz6il61NshwbPTPEdf37_7svxAbj5dN8urG-KEVplY0YHizFHby97RmjsQxtraCVkZoE7V1coIKXtmpKaV5V1tlbagqs70qhbiHF0cfcsLvs2Qcrv1ycEw2BHCnFouhTZKMM0L-vIf9C7McSzpCqVNpSmTqlD8SLnyJSlC307Rb23ctYy2v0pvj6W3pfT2UHq7L6IXJ-t5tYXuj-R3ywUQRyCV1biG-Pfu_9j-BLgUuuU</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Gugliandolo, Simone Giovanni</creator><creator>Pepa, Matteo</creator><creator>Isaksson, Lars Johannes</creator><creator>Marvaso, Giulia</creator><creator>Raimondi, Sara</creator><creator>Botta, Francesca</creator><creator>Gandini, Sara</creator><creator>Ciardo, Delia</creator><creator>Volpe, Stefania</creator><creator>Riva, Giulia</creator><creator>Rojas, Damari Patricia</creator><creator>Zerini, Dario</creator><creator>Pricolo, Paola</creator><creator>Alessi, Sarah</creator><creator>Petralia, Giuseppe</creator><creator>Summers, Paul Eugene</creator><creator>Mistretta, Frnacesco Alessandro</creator><creator>Luzzago, Stefano</creator><creator>Cattani, Federica</creator><creator>De Cobelli, Ottavio</creator><creator>Cassano, Enrico</creator><creator>Cremonesi, Marta</creator><creator>Bellomi, Massimo</creator><creator>Orecchia, Roberto</creator><creator>Jereczek-Fossa, Barbara Alicja</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5339-8038</orcidid></search><sort><creationdate>20210201</creationdate><title>MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)</title><author>Gugliandolo, Simone Giovanni ; Pepa, Matteo ; Isaksson, Lars Johannes ; Marvaso, Giulia ; Raimondi, Sara ; Botta, Francesca ; Gandini, Sara ; Ciardo, Delia ; Volpe, Stefania ; Riva, Giulia ; Rojas, Damari Patricia ; Zerini, Dario ; Pricolo, Paola ; Alessi, Sarah ; Petralia, Giuseppe ; Summers, Paul Eugene ; Mistretta, Frnacesco Alessandro ; Luzzago, Stefano ; Cattani, Federica ; De Cobelli, Ottavio ; Cassano, Enrico ; Cremonesi, Marta ; Bellomi, Massimo ; Orecchia, Roberto ; Jereczek-Fossa, Barbara Alicja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Diagnostic Radiology</topic><topic>Feature extraction</topic><topic>Histograms</topic><topic>Humans</topic><topic>Image classification</topic><topic>Imaging</topic><topic>Immunoglobulins</topic><topic>Internal Medicine</topic><topic>Interventional Radiology</topic><topic>Magnetic Resonance</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Multivariate analysis</topic><topic>Neuroradiology</topic><topic>Prospective Studies</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Radiation therapy</topic><topic>Radiology</topic><topic>Radiomics</topic><topic>Resonance</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Standardization</topic><topic>Texture</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gugliandolo, Simone Giovanni</creatorcontrib><creatorcontrib>Pepa, Matteo</creatorcontrib><creatorcontrib>Isaksson, Lars Johannes</creatorcontrib><creatorcontrib>Marvaso, Giulia</creatorcontrib><creatorcontrib>Raimondi, Sara</creatorcontrib><creatorcontrib>Botta, Francesca</creatorcontrib><creatorcontrib>Gandini, Sara</creatorcontrib><creatorcontrib>Ciardo, Delia</creatorcontrib><creatorcontrib>Volpe, Stefania</creatorcontrib><creatorcontrib>Riva, Giulia</creatorcontrib><creatorcontrib>Rojas, Damari Patricia</creatorcontrib><creatorcontrib>Zerini, Dario</creatorcontrib><creatorcontrib>Pricolo, Paola</creatorcontrib><creatorcontrib>Alessi, Sarah</creatorcontrib><creatorcontrib>Petralia, Giuseppe</creatorcontrib><creatorcontrib>Summers, Paul Eugene</creatorcontrib><creatorcontrib>Mistretta, Frnacesco Alessandro</creatorcontrib><creatorcontrib>Luzzago, Stefano</creatorcontrib><creatorcontrib>Cattani, Federica</creatorcontrib><creatorcontrib>De Cobelli, Ottavio</creatorcontrib><creatorcontrib>Cassano, Enrico</creatorcontrib><creatorcontrib>Cremonesi, Marta</creatorcontrib><creatorcontrib>Bellomi, Massimo</creatorcontrib><creatorcontrib>Orecchia, Roberto</creatorcontrib><creatorcontrib>Jereczek-Fossa, Barbara Alicja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gugliandolo, Simone Giovanni</au><au>Pepa, Matteo</au><au>Isaksson, Lars Johannes</au><au>Marvaso, Giulia</au><au>Raimondi, Sara</au><au>Botta, Francesca</au><au>Gandini, Sara</au><au>Ciardo, Delia</au><au>Volpe, Stefania</au><au>Riva, Giulia</au><au>Rojas, Damari Patricia</au><au>Zerini, Dario</au><au>Pricolo, Paola</au><au>Alessi, Sarah</au><au>Petralia, Giuseppe</au><au>Summers, Paul Eugene</au><au>Mistretta, Frnacesco Alessandro</au><au>Luzzago, Stefano</au><au>Cattani, Federica</au><au>De Cobelli, Ottavio</au><au>Cassano, Enrico</au><au>Cremonesi, Marta</au><au>Bellomi, Massimo</au><au>Orecchia, Roberto</au><au>Jereczek-Fossa, Barbara Alicja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)</atitle><jtitle>European radiology</jtitle><stitle>Eur Radiol</stitle><addtitle>Eur Radiol</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>31</volume><issue>2</issue><spage>716</spage><epage>728</epage><pages>716-728</pages><issn>0938-7994</issn><eissn>1432-1084</eissn><abstract>Objectives Radiomic involves testing the associations of a large number of quantitative imaging features with clinical characteristics. Our aim was to extract a radiomic signature from axial T2-weighted (T2-W) magnetic resonance imaging (MRI) of the whole prostate able to predict oncological and radiological scores in prostate cancer (PCa). Methods This study included 65 patients with localized PCa treated with radiotherapy (RT) between 2014 and 2018. For each patient, the T2-W MRI images were normalized with the histogram intensity scale standardization method. Features were extracted with the IBEX software. The association of each radiomic feature with risk class, T-stage, Gleason score (GS), extracapsular extension (ECE) score, and Prostate Imaging Reporting and Data System (PI-RADS v2) score was assessed by univariate and multivariate analysis. Results Forty-nine out of 65 patients were eligible. Among the 1702 features extracted, 3 to 6 features with the highest predictive power were selected for each outcome. This analysis showed that texture features were the most predictive for GS, PI-RADS v2 score, and risk class; intensity features were highly associated with T-stage, ECE score, and risk class, with areas under the receiver operating characteristic curve (ROC AUC) ranging from 0.74 to 0.94. Conclusions MRI-based radiomics is a promising tool for prediction of PCa characteristics. Although a significant association was found between the selected features and all the mentioned clinical/radiological scores, further validations on larger cohorts are needed before these findings can be applied in the clinical practice. Key Points • A radiomic model was used to classify PCa aggressiveness. • Radiomic analysis was performed on T2-W magnetic resonance images of the whole prostate gland. • The most predictive features belong to the texture (57%) and intensity (43%) domains.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32852590</pmid><doi>10.1007/s00330-020-07105-z</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-5339-8038</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0938-7994
ispartof European radiology, 2021-02, Vol.31 (2), p.716-728
issn 0938-7994
1432-1084
language eng
recordid cdi_proquest_miscellaneous_2437853172
source Springer Nature
subjects Diagnostic Radiology
Feature extraction
Histograms
Humans
Image classification
Imaging
Immunoglobulins
Internal Medicine
Interventional Radiology
Magnetic Resonance
Magnetic Resonance Imaging
Male
Medical imaging
Medicine
Medicine & Public Health
Multivariate analysis
Neuroradiology
Prospective Studies
Prostate cancer
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - radiotherapy
Radiation therapy
Radiology
Radiomics
Resonance
Retrospective Studies
Risk
Standardization
Texture
Ultrasound
title MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T00%3A11%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRI-based%20radiomics%20signature%20for%20localized%20prostate%20cancer:%20a%20new%20clinical%20tool%20for%20cancer%20aggressiveness%20prediction?%20Sub-study%20of%20prospective%20phase%20II%20trial%20on%20ultra-hypofractionated%20radiotherapy%20(AIRC%20IG-13218)&rft.jtitle=European%20radiology&rft.au=Gugliandolo,%20Simone%20Giovanni&rft.date=2021-02-01&rft.volume=31&rft.issue=2&rft.spage=716&rft.epage=728&rft.pages=716-728&rft.issn=0938-7994&rft.eissn=1432-1084&rft_id=info:doi/10.1007/s00330-020-07105-z&rft_dat=%3Cproquest_cross%3E2478670145%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-a3de521c0af4fc092ce38aa9c3468e0c596b8344f184706a2d9a57ae56d8f5933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2478670145&rft_id=info:pmid/32852590&rfr_iscdi=true